Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
14.19
-1.11 (-7.25%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $533.84 million as of August 14, 2026. Its market cap has increased by 173.92% in one year.
Market Cap
533.84M
Enterprise Value
303.87M
1-Year Change
173.92%
Ranking
Category
Stock Price
$14.19
ChartMarket Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $533.84M, an increase of 32.77%. That is a compound annual growth rate of 12.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 533.84M | 27.86% |
| Dec 31, 2025 | 417.53M | 10.56% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ARS Pharmaceuticals | 561.88M |
| Artiva Biotherapeutics | 559.79M |
| Ovid Therapeutics | 552.69M |
| Prime Medicine | 549.72M |
| MapLight Therapeutics | 544.94M |
| Zura Bio | 533.77M |
| Evommune | 531.68M |
| Adlai Nortye | 530.00M |